Review on Clostridium Role in Autoimmune Disease Mechanisms

Jing-Yi Zhan authored a 14.6 KB literature review document synthesizing evidence on Clostridium's role in autoimmune diseases. The review delineates immunomodulatory mechanisms by which species like Clostridium butyricum and Faecalibacterium prausnitzii influence conditions such as IBD, RA, and T1D. It was last updated in March 2026.

Use Cases

• Extract mentions of specific autoimmune diseases like IBD, RA, and T1D for literature mining on disease-mechanism associations.
• Identify discussed Clostridium species and metabolites for building a taxonomy of probiotic therapeutic targets.
• Parse sections on therapeutic mechanisms to train an NLP model for classifying immunomodulatory pathways in medical literature.

Strengths

• Synthesizes current evidence from multiple studies, as stated in the description.
• Focuses on a specific, high-interest research area linking Clostridium probiotics to autoimmune diseases.
• Released under a permissive CC BY 4.0 license for reuse.

Limitations

• The data is a single 14.6 KB DOCX file, representing a literature review, not a quantitative dataset for direct analysis.
• Contains no structured tabular data, columns, or sample records for statistical or machine learning modeling.
• Scope is limited to the synthesized evidence and arguments presented within the single review document.

Provenance

Source

figshare, author Jing-Yi Zhan.

Collection Method

Literature review synthesizing current evidence.

Time Range

null

Freshness

Last updated 2026-03-25.

Geography

null